The expert continued: " If your blood pressure is within a healthy range and you have no heart-related concerns, short-term use of decongestants as directed is generally safe. However, for individuals ...

GSK (NYSE:GSK) announced Tuesday that the EU drug regulator has agreed to review depemokimab, an experimental monoclonal antibody targeting a class of cell signaling molecules called interleukin-5, ...

In CRS with and without nasal polyps, medical treatment, including nasal and oral corticosteroids, is the first therapeutic option. The treatment of CRS still remains an unmet need ...

Nasal steroids provided the most significant benefit, especially when compared to montelukast. Nasal antihistamines also ...

EMA accepts for review GSK’s MAA for depemokimab for use in asthma with type 2 inflammation and CRSwNP: London, UK Wednesday, January 29, 2025, 09:00 Hrs [IST] GSK plc announced ...

There are many different types of allergy nasal sprays available on the market, including antihistamine sprays, steroid sprays, and saline sprays. When choosing the best allergy nasal spray ...

The China National Medical Products Administration (NMPA) has approved GSK’s Nucala (mepolizumab) as an add-on treatment with intranasal corticosteroids to treat chronic rhinosinusitis with nasal ...